Healthcare - Biotechnology - NASDAQ - GB
$ 16.0
-8.57 %
$ 1.81 B
Market Cap
-10.32
P/E
INCOME STATEMENT
6.85 M
REVENUE
-171 M
OPERATING INCOME
-151 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Centessa Pharmaceuticals plc
| Revenue | 6.85 M |
| Cost Of Revenue | 787 K |
| Gross Profit | 6.07 M |
| Operating Expenses | 178 M |
| Operating Income | -171 M |
| Other Expenses | -20.2 M |
| Net Income | -151 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 6.9 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0.8 | 0.1 | 34 K | 0 | 0 |
| Gross Profit | 6.1 | (0.1) | 34 K | 0 | 0 |
| OPERATING INCOME | |||||
| Operating Expenses | 178.1 | 210.3 | 139.3 | 10.4 | 5.1 |
| Selling, General and Administrative Expenses | 53.7 | 55.2 | 43.0 | 1.1 | 0.8 |
| Research and Development Expenses | 124.4 | 155.1 | 96.3 | 9.3 | 4.3 |
| Operating Income | (171.3) | (212.3) | (139.3) | (10.4) | (5.1) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 9.9 | 7.0 | 2.5 | 0.4 | 0.1 |
| Total Other Income | (4.9) | (4.7) | (6.9) | (0.2) | 8 K |
| Pre-Tax Income | (176.1) | (217.0) | (381.7) | (10.7) | (5.1) |
| NET INCOME | |||||
| Tax Provision | (25.1) | (0.7) | 0.1 | 0.4 | 0.2 |
| Net Income | (151.1) | (216.2) | (381.9) | (11.0) | (5.3) |
| EPS | 1.57 | 2.31 | 4.24 | 0.0777 | 0.0745 |